Request Information
Press Release
October 1, 2019

Last October, Turn Therapeutics was featured on Worldwide Business with kathy ireland®, where Turn founder and CEO Bradley Burnam shared his unique story of what makes Turn Therapeutics product different.

PharPoint Research is proud to have worked with the Turn Therapeutics team as they continue to improve the lives and treatment options for patients of infectious disease.

View their interview with Kathy Ireland, which includes a short clip featuring PharPoint’s Chief Scientific Officer Dr. Jennifer Elder, below:

How and When to Consider a Data Monitoring Committee
Adaptive Trial Design and the CRO Landscape